The outcome of donor screening for Human T‐Cell Lymphotropic Virus infection in the Netherlands
- 6 September 2011
- journal article
- Published by Wiley in Vox Sanguinis
- Vol. 102 (3), 198-203
- https://doi.org/10.1111/j.1423-0410.2011.01538.x
Abstract
Blood donor screening reduces the infectious hazards related to blood transfusion, but the range of agents to be screened for is debatable. In 1993, the screening of all blood donations for Human T-Cell Lymphotropic virus (HTLV) was introduced in The Netherlands. We analysed the outcome and costs of HTLV donor screening. For the years 2001-2010, the number of HTLV infections among new and regular donors was used to estimate the prevented number of HTLV-infected donors in the donor pool and the amount of morbidity prevented among recipients. Human T-Cell Lymphotropic virus screening in The Netherlands detects per year on average 1·4 infected new donors and 0·5 infected regular donors. The prevalence among new donors is 30 times higher than the incidence among regular donors. Without HTLV screening, 14 HTLV-infected donors would be donating blood, causing 0·8 to 0·007 cases of HTLV disease per year. The lack of accurate estimators for infectivity and pathogenicity hampers the estimation of morbidity and mortality that HTLV-infected transfusions would cause. Leucodepletion may be as effective as HTLV donor screening; its effect on HTLV transmission should be studied.Keywords
This publication has 23 references indexed in Scilit:
- The PROTON study: profiles of blood product transfusion recipients in the NetherlandsVox Sanguinis, 2010
- Lookback study of HTLV-1 and 2 seropositive donors and their recipients in Belo Horizonte, BrazilTransfusion Medicine, 2009
- Blood safety strategies for human T‐cell lymphotropic virus in EuropeVox Sanguinis, 2009
- Detection of HTLV-I and -II in Scottish blood donor samples and archive donationsVox Sanguinis, 2006
- Effectiveness of human T‐lymphotropic virus (HTLV) recipient tracing (lookback) and the current HTLV‐I and ‐II confirmatory algorithm, 1999 to 2004Transfusion, 2006
- Leukocyte reduction and HTLV-I: is the glass half empty or half full?Blood, 2003
- Transmission of Human T Cell Lymphotropic Virus (HTLV) Type II by Transfusion of HTLV-I-Screened Blood ProductsThe Journal of Infectious Diseases, 1994
- Transmission of human T‐lymphotrophic virus type I infection to a neonatal infant by transfusion of washed and irradiated red cellsTransfusion, 1993
- A prospective study of transmission by transfusion of HTLV‐I and risk factors associated with seroconversionInternational Journal of Cancer, 1992
- Rapid Development of Myelopathy after HTLV-I Infection Acquired by Transfusion during Cardiac TransplantationThe New England Journal of Medicine, 1990